ArticleFrontiers in medicine2023
The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis.
Brianne E Barker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it